A novel prognostic nomogram was developed to assess cancer-specific survival (CSS) in patients with distant-metastatic hepatocellular carcinoma (dm-hcc). Using data from 651 patients, the model identified key predictors: alpha-fetoprotein levels, tumor grade, T stage, and treatment types. The nomogram achieved a c-index of 0.721 and 0.726 in training and validation sets, respectively, demonstrating strong predictive reliability. This tool allows clinicians to effectively stratify patients into low- and high-risk groups, aiding in tailored treatment strategies.
Journal Article by Heng Q, Leng Y, Bai G and Yu H in Medicine (Baltimore)
Copyright © 2025 the Author(s). Published by Wolters Kluwer Health, Inc.